Trial intelligence / Profile preview

Dexmedetomidine vs Ketamine for Shivering in Vaginal Hysterectomy

NCT05481281Phase 3Unknown

Sponsor
Hamdard University
Start
Aug 2022
Primary completion
Jan 2023
Modality
Small Molecules
01

Overview

Phase 3, randomised trial comparing Group Dexmedetomidine with Group Ketamine (2 arms). Primary endpoint: Change in Shivering grade at 60 months. Status: unknown.

02

Drugs

dexmedetomidineketamine

Beyond the preview

Go deeper on NCT05481281.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05481281.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call